Isoform-Specific Activation of Latent Transforming Growth Factor β (LTGF-β) by Reactive Oxygen Species
- 1 December 2006
- journal article
- Published by Radiation Research Society in Radiation Research
- Vol. 166 (6) , 839-848
- https://doi.org/10.1667/rr0695.1
Abstract
The three mammalian transforming growth factor beta (TGF-beta) isoforms are each secreted in a latent complex in which TGF-beta homodimers are non-covalently associated with homodimers of their respective pro-peptide called the latency-associated peptide (LAP). Release of TGF-beta from its LAP, called activation, is required for binding of TGF-beta to cellular receptors, making extracellular activation a critical regulatory point for TGF-beta bioavailability. Our previous work demonstrated that latent TGF-beta1 (LTGF-beta1) is efficiently activated by ionizing radiation in vivo and by reactive oxygen species (ROS) generated by Fenton chemistry in vitro. In the current study, we determined the specific ROS and protein target that render LTGF-beta1 redox sensitive. First, we compared LTGF-beta1, LTGF-beta2 and LTGF-beta3 to determine the generality of this mechanism of activation and found that redox-mediated activation is restricted to the LTGF-beta1 isoform. Next, we used scavengers to determine that ROS activation was a function of OH(.) availability, confirming oxidation as the primary mechanism. To identify which partner of the LTGF-beta1 complex was functionally modified, each was exposed to ROS and tested for the ability to form a latent complex. Exposure of TGF-beta1 did not alter its ability to associate with LAP, but exposing LAP-beta1 to ROS prohibited this phenomenon, while treatment of ROS-exposed LAP-beta1 with a mild reducing agent restored its ability to neutralize TGF-beta1 activity. Taken together, these results suggest that ROS-induced oxidation in LAP-beta1 triggers a conformational change that releases TGF-beta1. Using site-specific mutation, we identified a methionine residue at amino acid position 253 unique to LAP-beta1 as critical to ROS-mediated activation. We propose that LTGF-beta1 contains a redox switch centered at methionine 253, which allows LTGF-beta1 to act uniquely as an extracellular sensor of oxidative stress in tissues.Keywords
This publication has 46 references indexed in Scilit:
- Asbestos-derived reactive oxygen species activate TGF-β1Laboratory Investigation, 2004
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- Latent TGF‐β binding protein‐3 (LTBP‐3) requires binding to TGF‐β for secretionFEBS Letters, 2002
- TRANSFORMING GROWTH FACTOR-β1 (TGF-β1): A POTENTIAL RECOVERY SIGNAL IN THE POST-ISCHEMIC KIDNEYRenal Failure, 2002
- Chronic liver injury, TGF-β, and cancerExperimental & Molecular Medicine, 2001
- Oxidative Protein Cross-linking Reactions Involvingl-Tyrosine in Transforming Growth Factor-β1-stimulated FibroblastsJournal of Biological Chemistry, 2001
- Reactive Oxygen Species Act at both TGF-β-Dependent and -Independent Steps during Induction of Apoptosis of Transformed Cells by Normal CellsExperimental Cell Research, 1996
- Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβThe British Journal of Radiology, 1995
- Transforming growth factor beta: the good, the bad, and the ugly.The Journal of Experimental Medicine, 1994
- Transforming growth factor-β1 induces extracellular matrix formation in glomerulonephritisCell Differentiation and Development, 1990